Asia-Pacific is estimated to be the fastest growing region during the period under study owing to the rapid technological advances in medicine going on in the developing economies such as China and India.
The global market for pediatric interventional cardiology in 2020 is largely dominated by the Americas, especially in the U.S. due to the increasing instances of cardiac diseases among the children. APAC region is poised to exhibit highest growth rate during the forecast period due to the flooding investments in pediatrics by major healthcare players in this region, especially from China and India. The improved healthcare services and governmental healthcare reforms and increased awareness among people drive the market for pediatric interventional cardiology in the APAC region.
Sample Companies Profiled in this Report are:
Claritas Genomics, Inc.
Clarity Medical Systems, Inc.
Covidien Public Limited Company
Edwards Lifesciences
Envision Radiology
10+
Table of Contents
Methodology
LOADING...
